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Abstract
Vascular changes underlying headache in migraine patients induced by Glyceryl trinitrate (GTN) were previously studied
with various imaging techniques. Despite the long history of medical and experimental use of GTN, its effects on the brain
vasculature are still poorly understood presumably due to low spatial resolution of the imaging modalities used so far. We
took advantage of the micrometer-scale vertical resolution of two-photon microscopy to differentiate between the
vasodynamic effects of GTN on meningeal versus cortical vessels imaged simultaneously in anesthetized rats through either
thinned skull or glass-sealed cranial window. Intermediate and small calibre vessels were visualized in vivo by imaging
intravascular fluorescent dextran, and detection of blood flow direction allowed identification of individual arterioles and
venules. We found that i.p.-injected GTN induced a transient constriction of meningeal arterioles, while their cortical
counterparts were, in contrast, dilated. These opposing effects of GTN were restricted to arterioles, whereas the effects on
venules were insignificant. Interestingly, the NO synthase inhibitor L-NAME did not affect the diameter of meningeal vessels
but induced a constriction of cortical vessels. The different cellular environment in cortex versus meninges as well as distinct
vessel wall anatomical features probably play crucial role in the observed phenomena. These findings highlight differential
region- and vessel-type-specific effects of GTN on cranial vessels, and may implicate new vascular mechanisms of NO-
mediated primary headaches.
Citation: Pryazhnikov E, Kislin M, Tibeykina M, Toptunov D, Ptukha A, et al. (2014) Opposite Reactivity of Meningeal versus Cortical Microvessels to the Nitric
Oxide Donor Glyceryl Trinitrate Evaluated In Vivo with Two-Photon Imaging. PLoS ONE 9(2): e89699. doi:10.1371/journal.pone.0089699
Editor: Vincenzo Lionetti, Scuola Superiore Sant’Anna, Italy
Received July 18, 2013; Accepted January 23, 2014; Published February 28, 2014
Copyright:  2014 Pryazhnikov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Academy of Finland (ROSim, Photonics Program) and Center for International Mobility (CIMO) of Finland.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have read the journal’s policy and have the following conflicts. EP and MT are part-time employees of Neurotar LTD. LK is a
co-owner of Neurotar LTD. Other authors do not have competing interests. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data
and materials.
* E-mail: leonard.khirug@helsinki.fi
Introduction
Vascular headaches were traditionally associated with abnormal
changes in blood flow in the intracranial vessels [1], and nowadays
the role of vessels in primary or secondary headaches remains a
matter of continuous debate [2,3,4,5,6,7]. In order to obtain novel
information on intracranial vascular processes during headache, a
variety of methods have been employed, ranging from transcranial
Doppler (TCD) [8] to high resolution magnetic resonance
angiography (MRA) [6]. In animal models, closed cranial window
with intravital epifluorescence microscopy is one of the best
established methods since the end of 90s [9]. Both in human and
animal studies, observational methods are often complemented
with a triggering method, commonly the administration of the NO
donor glyceryltrinitrate (GTN) [10,11,12,13]. This medicine is
known for its ability to trigger headaches in healthy subjects and to
initiate migraine attacks in patients [11,14,15]. One important
advantage of the GTN-triggered headache model is the temporal
control of events following this drug administration. Thus, there
are two phases of the GTN-induced headache: the initial pain
starts immediately after GNT infusion and persists only for about
30 min, whereas the secondary migraine-like pain develops after
several hours [10,16]. Notably, headache is also the main side
effect of GTN in cardiology, where this medicine is widely used to
counteract the ischemic conditions.
Vasodilation of large intracranial cerebral arteries in response to
GTN was shown in human volunteers using transcranial Doppler
ultrasonography and single-photon emission computed tomogra-
phy (SPECT) based on measurements of the cerebral blood flow
[17]. Likewise, it has been shown in monkeys, using angiography,
that the i.v. infusion of the GTN induced vasodilation of the
middle cerebral artery (MCA) [18]. Using laser Doppler flowmetry
(LDF), the dilatory effects of GTN on both MCA and the middle
meningeal artery (MMA) have been reported [19]. Using 3T
MRI, a transient vasodilatation (by up to 30%) of both large
arteries has also been detected immediately after infusion of the
GNT [3]. For all these methods, the main limiting factor is their
poor spatial resolution that restricts the measurements to only
large vessels such as MMA or MCA, while leaving the dynamics of
smaller vessels beyond the reach of the techniques traditionally
employed in vasculature imaging studies. Therefore, it remains
unclear whether smaller vessels are dilated in response to GTN
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similarly to the large ones. Elucidating this issue is important,
because small size meningeal vessels are innervated by caltitonin
gene-related peptide containing nerves (CGRP) [20], which
suggests that small vessel dynamics may play a role in migraine
pathogenesis.
Already early studies showing differential sensitivity of proximal
versus distal parts of the isolated middle cerebral artery to GTN
[21] have indicated that the effects of GTN might be region
specific. More recently, Greco and co-workers used LDF on
anesthesized rats to demonstrate that GTN transiently reduced
blood flow in dural vessels, but not in the cortical ones [22].
However, the limited spatial resolution of this technique made it
impossible to distinguish between veins and arteries, and allowed
only partial separation of meningeal and cortical signals.
In the present study, we explored the effects of GTN on the
cerebral circulation with unprecedented temporal and spatial
resolution by using two-photon laser scanning microscopy
(TPLSM) in anesthetized rats, where vessels were visualized by
an i.v. injection of FITC dextran. Unexpectedly, we found that
meningeal (dural) arterioles were abruptly constricted, while
cortical arterioles were dilated. In contrast to the previous reports
of high sensitivity of large veins to GNT, we found that small
venules were nearly insensitive to this NO donor.
Materials and Methods
Ethics Statement
All experiments on animals were performed with accordance to
local guidance for animal care (The Finnish Act on Animal
Experimentation (62/2006)). Animal license (ESAVI/2857/
04.10.03/2012) from local authority (ELA¨INKOELAUTA-
KUNTA-ELLA) was obtained and included all procedures used
in this study.
Animals and surgical procedures
Twenty seven Wistar rats ranging from 80 to 140 g in weight
were used in this study (age range 21–35 days). The rats were kept
in individual cages in the certified University’s animal facility and
provided with food and water ad libitum. Only visually healthy,
drug and test-naı¨ve animals of both sexes were selected for
experiments. Animals were randomly allocated to experimental
groups. To address the RRR-policy requirements, the group size
was selected based on the following criteria: i) normality of data
distribution, ii) degree of data scatter (variability), iii) confidence
level of 95% (P,0.05) as a target statistical significance. Every
animal was used in only one imaging session and received only one
experimental treatment. Rat was selected for this study because
this species offers a more relevant animal model in terms of
physiology of cerebral blood flow as compared to mice [23].
Furthermore, many earlier studies of the effects of GTN on
cerebral vessels were performed on rats [9,12,13,19,22].
Rats were anaesthetized (i.p.) with mixture of ketamine (80 mg/
kg) and xylazine (10 mg/kg). Ketamine/xylazine mixture was re-
admininistured every hour if necessary at half-the-original dose. A
subset of experiments was performed with urethane (1 g/kg i.p.).
Body temperature was maintained using a heating pad. Arterial
oxygen saturation and heart rate were monitored using a pulse
oximeter (MouseOx, Starr Life Sciences, USA) attached to the
rat’s hind paw. Parameters were constantly monitored to ensure
that physiological state of the rat was stable. Unstable or non-
adequate level of anaesthesia was one of criteria for termination of
experiment and exclusion of the data from analysis.
For in vivo monitoring of meningeal and cortical blood vessel
diameter, we used two approaches: implantation of cranial
window [24] and skull thinning [25] (the protocols were adapted
for rats). During preparation to surgery a subcutaneous injection of
0.1% lidocaine was used to reduce local pain at the incision site.
For cranial window formation, a ,363 mm round craniotomy
was performed over the parietal cortex. Cranial bone was carefully
removed, while dura mater remained intact. Great care was taken to
minimize any possible damage to dura mater. Animals with
damaged dura mater or haemorrhage were excluded from
experiments and euthanized. The brain was then covered with
sterile cortical buffer (125 mM NaCl, 5 mM KCl, 10 mM glucose,
10 mM HEPES, 2 mM CaCl2 and 2 mM MgSO4 in distilled
H2O), and a 5 mm diameter No. 1.5 glass coverslip (Electron
Microscopy Sciences, USA) was placed over the window and
sealed using dental cement. For thinned skull preparation, we
gently and carefully thinned a ,262 mm region of the parietal
skull until the bone thickness reached 30–50 mm. The main
advantages of the open skull (cranial window) preparation are its
relative simplicity, good signal-to-noise ratio and larger depth of
imaging. The main disadvantage of this preparation is a relatively
strong damaging effect on superficial meningeal and cortical
tissues, which is especially apparent during the first post-surgery
hours. Therefore, two-photon imaging sessions were performed
after 2 days of recovery after cranial window implantation. In
small subset of animals we observed development of local
inflammation in the cranial window 2 days after window
implantation: these animals were excluded from experiments
and euthanized. In comparison to open skull, the thinned skull
preparation minimizes the damage to the tissue but restricts the
depth of optimal visualization. In this preparation, imaging was
performed shortly after completing the surgery.
Multiphoton imaging
Animals were imaged with the FV1000MPE two-photon
microscope (Olympus, Japan) using the 25X water immersion
high NA objective specially designed for in vivo two-photon
imaging. Image stacks were collected with a vertical step of 2–
3 mm. FITC dextran (MW = 2000 kDa) was pre-injected in the rat
tail vein for visualization of brain vasculature. Fluorescence
excitation was achieved with MaiTai femtosecond laser tuned to
800 nm. Emission light was collected using a band pass filter (515–
560 nm). In every experiment one imaging field comprising 500
by 500 microns in xy axes was imaged. Using the cranial window
preparation, in rats injected with FITC-dextran we were able to
visualize the blood flow in small arteries and veins with the depth
of penetration up to 600 mm below the cortical surface. Small
stacks of images comprising both meningeal and cortical layers
were acquired every 20–30 seconds. For better illustration
purposes 4 neighbour timepoints were averaged to plot one point
on the graph. We reconstructed 3D images of brain vasculature to
verify our ability to distinguish between meningeal and cortical
blood vessels. Reconstructions were done using Imaris software
(Bitplane, Switzerland). For identification of vessel type (arterioles
versus venules), we performed longitudinal line scans as described
before [26]. Briefly, repetitive line scans along the axis of the
vessels were acquired to form an image where moving erythrocytes
produce streaks with a measurable slope. Using this slope, it was
possible to determine the direction of blood flow and, by following
the vessel branch bifurcations, deduce the type of each vessel
(arteriole or venule).
Drugs
We used intraperitoneal injection of GTN (Orion Pharma,
Finland) in the dose of 10 mg/kg as described by Srikiatkhachorn
et al [27] or Greco et al [22]. Since this solution contains also
GTN Triggers Constriction of Meningeal Arterioles
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ethanol and propylene glycol, solution containing these com-
pounds without GTN was used as a vehicle control. L-NAME
(Sigma, USA) was delivered intraperitoneally (40 mg/kg) in PBS
solution. FITC-conjugated dextran (MW = 2000 kDa, Sigma,
USA) was dissolved in PBS to obtain a 5% solution and 150 mL
were delivered intravenously in the tail vein for visualisation of
blood vessels.
Vessel diameter measurement
Measurements were done using the line profile function of
ImageJ software. After manual drawing of the line across the
selected segment of the vessel, line profile was plotted. Diameter
was calculated as the average width at the half-height of the line
profile plot. For measurement of diameter, we selected between 3
and 5 segments in different parts of one vascular element (i.e. we
measured diameter changes in 3 to 5 different segments of a
particular arteriole or venule). The segment was defined as the
part of a vessel between two successive branching points or, if less
than 3 branching points were present in the area of imaging, the
regions for line profile analysis were selected at a distance of at
least 100 mm from one to another. We then calculated the mean
value by pooling the data from these segments, and used this mean
value as the outcome of a particular experiment. This procedure
ensured that each vascular element (e.g., a meningeal arteriole)
from each particular animal contributed only once (n = 1) to the
plots representing the diameter changes. Data were double-
checked with automated ‘‘vessel diameter’’ plugin for ImageJ. The
results from both methods were compared, and no significant
differences in the outputs of the measurement methods were
found.
Blood pressure measurement
In the separate set of experiments blood pressure was measured
in 4 male Wistar rats. Rats were initially anesthetized with
Isoflurane (4% for induction 2% for maintenance) for the duration
of surgical procedures (10 minutes). After canulation of right
femoral artery with 24G catheter, anesthesia was switched to
urethane (1 g/kg i.p.). The catheter was then connected to Datex
Cardiocap II monitor (SOMA Technology Inc., Bloomfield, USA)
through saline-filled pressure transducer for continuous blood
pressure monitoring. After the surgery and switch of anesthesia,
animals were allowed to recover for 15 minutes prior to recording.
For statistical analysis values were taken every minute for 5 min
before and 20 min after i.p. injection of GTN (10 mg/kg). Body
temperature of the animals was maintained throughout the
experiment using homeothermic blanket (Harvard Apparatus,
Holliston, USA).
Graphs and statistical analysis
Attempts were made to ensure blinded data analysis, by
assigning the analysis tasks to those co-authors who did not
participate in a particular imaging experiment. Graphs were
plotted using Origin software (Microcal, USA). All graphs were
normalized to the last two minutes preceding the drug adminis-
tration. Images were acquired once every 20 or 30 seconds but for
the better graphical presentation on graphs we averaged
neighbour values to get one point every 2 minutes. For comparison
of effects of GTN and other drugs on vessel diameter, we
calculated mean area under the curve (AUC) for individual graphs
plotted from original data. Namely, we used the ‘‘Integrate’’ tool
of Origin to calculate area between the line drawn through the
baseline (pre-injection) diameter level and the line delineating the
changes in diameter from 0 to 16 minutes after drug injection.
Thus, in case of vasoconstriction we obtained negative values of
AUC (stronger constriction yielding more negative value) and in
case of dilation - positive values. Statistical analysis was performed
by EP and MK. The N values refer to the number of independent
replications, each of them performed in a different animal. Data
were presented as mean 6 SEM. For statistical analyses using
Student t-test, the P , 0.05 value was considered significant. Due
to specific features of vascular architecture, in some of the
experiments only specific types of vessels were visualized (i.e. only
meningeal venules, cortical arterioles and cortical venules but not
meningeal arterioles). This explains why N value may be not equal
inside experimental group for different types of vessels.
Results
Visualization of meningeal and cortical vessels and
distinguishing arteries from veins
Acquisition of z-stacks in a time-lapse mode followed by the
reconstruction of 3D images (Figure 1) allowed us to clearly
distinguish meningeal blood vessels from the cortical vessels. Thus,
Figure 1 (B) shows a distinct gap, i.e. the space between dural and
cortical vessels. In order to distinguish arteries from veins, we
performed longitudinal line scans and determined the direction of
blood flow in each vessel of interest (see Methods for details). In
summary, we optimized the high resolution tools for comparative
analysis of the functional state of arterioles versus venules and of
meningeal vessels versus cortical ones.
Acute effects of GTN on vessel diameter
The average diameter of investigated vessels was calculated as
17.462 mm for meningeal arterioles, 22.864 mm for meningeal
venules, 36.166 mm for cortical arterioles and 3868 mm for
cortical venules. After injection of GTN there was a clear
vasodilatatory effect on cortical arterioles (n = 6; P,0.05, Figure
2A,B,C) consistent with many previous observations
[3,17,18,19,22]. There was also a clear trend for vasodilation of
venules (Figure 2A,D,E) but this effect did not reach the
significance (n = 8; P = 0.09). Interestingly, in arterioles the
development of dilation was much faster than in venules (compare
Figures 2B and 2D). Unexpectedly, in contrast to vasodilation of
cortical vessels, GTN caused a significant vasoconstriction of
meningeal arterioles (n = 6, P = 0.001, Figure 3A,B,C). This
vasoconstriction of meningeal arterioles was transient and
apparently subsided by 16 minutes (Figure 3B). No significant
effects were observed in meningeal venules (n = 5; P = 0.61, Figure
3A,D,E).
Figure 1. Upper (A) and side (B) views of 3D reconstruction of
meningeal and cortical arterioles (red color) and venules (blue
color) obtained from a typical z-stack of brain images. Note the
clear gap between meningeal (dural) and cortical vessels in the side
view projection shown (B). Scale bar 50 mm.
doi:10.1371/journal.pone.0089699.g001
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Unlike GTN, injection of vehicle did not produce any
significant changes in the diameter of all studied vascular regions
(empty circles in Figures 2 and 3).
To verify independence of GTN effects from the type of
preparation (i.e. open cranial window), similar experiments were
performed on the thinned skull preparation. As shown in Figure
S1, the effect of meningeal vasoconstriction was similar to the
action of GTN in open cranial window preparation (p,0.01),
although the dilation of cortical vessels was weaker in the case of
thinned skull (p = 0.14 for cortical arterioles, Figure S1).
Since GTN is known to lower the systemic blood pressure [22],
the observed vasoconstriction of meningeal arterioles may have
resulted from a decrease in systemic blood pressure. We therefore
asked whether in our experiments the injection of GTN produces
changes in rat systemic blood pressure. We found that, within 15 s
the GTN injection induced a drop in systolic blood pressure on
average by 34% (n = 4, from 111.562.7 mmHg to 73.2
61.6 mmHg, Figure S2). The decreased blood pressure remained
stable throughout the remaining 20 minutes of the measurement
time.
Recent data indicate that, in the in vivo experiments, the type of
general anaesthesia can determine the probability of migraine
related cortical spreading depression [28] and responsiveness of
astrocytes [29], which constitute a likely target of GTN-derived
NO. In order to test the role of ketamine anaesthesia in the
modulatory effects of GTN, we performed a subset of experiments
with urethane (1 g/kg i.p.) As shown in Figure S3, change of
anaesthesia type did not influence significantly the effects of GTN
on meningeal arterioles which still constricted after peritoneal
injection of this NO donor (n = 5, p,0.001). The lack of
significant vasodilation in cortical arterioles under urethane
anesthesia may be explained by the effect-modulating influence
of urethane. Again, as in the case of thinned skull preparation, we
observed a clear trend to cortical vasodilation in the urethane
experiments.
Thus, in different types of anaesthesia (ketamine versus urethane)
and experimental approaches for blood vessels visualization (open
cranial window versus thinned skull) we consistently reproduced the
main novel finding of early vasoconstriction of dural vessels in
response to the NO donor GTN.
The role of NO synthase blockade on the effects of GTN
To explore the role of NO in the differential action of GTN on
meningeal and cortical vessels, we used the non-specific blocker of
NO synthase L-NAME. Previously it has been shown that L-
NAME increased systemic blood pressure after infusion in rats
Figure 2. Effects of GTN on cortical vessels in the open cranial window preparation. A, examples of cortical vessels before (upper image)
and after GTN administration (lower image). B, the normalized diameter of cortical arterioles after injection of the GTN (filled circles) or vehicle (empty
circles), real diameter before application 36.166 mm for cortical arterioles and 3868 mm for cortical venules. C, comparison of changes in the area
under curve (AUC) in GTN versus vehicle in cortical arterioles (n = 6 and n= 3, respectively). D and E, the same for cortical venules (n = 8 and n= 4,
respectively). Note that GTN significantly changed the diameter of arterioles (* = P,0.05) but not venules (P = 0.09). Scale bar 25 mm.
doi:10.1371/journal.pone.0089699.g002
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[30] likely due to the constriction of vessels. Consistent with this
view, the i.p. injection of 40 mg/kg L-NAME induced vasocon-
striction of cortical arterioles (n = 8; P,0.001, Figure 4A,B,C) and
venules (n = 8; P,0.01). The action of L-NAME on meninges was
highly variable, but on average the diameter of meningeal
arterioles and venules changed little (n = 8; P = 0.47 and n = 4;
P = 0.71, respectively, Figure 4 D,E,F). These results point to a key
role of NO in control of blood flow in cortical but not meningeal
vessels.
Discussion
In this study we, for the first time, employed two-photon laser
scanning microscopy (TPLSM) to visualize with high temporal and
spatial resolution the acute effects of the GTN on meningeal
(dural) versus cortical vessels. Using this technique, we found that
cortical and dural vessels responded in opposing direction (with
vasodilation versus vasoconstriction) to the same treatment with the
NO donor GTN.
The role of brain vessels in headache
In the classical theory of Woolf [1], vasodilation was for long
time considered as the leading reason for primary headaches like
migraine. Nevertheless, recent data indicated that headache could
be eliminated by substances which do not show any vasoconstric-
tory effects, e.g. novel CGRP receptor antagonists [31]. Further-
more, substances like prostanoid PGF2a with strong vasoconstric-
tory effects do not produce headache in volunteers [5].
Involvement of vasculature in migraine pain pathogenesis is still
actively debated [2,3,4,6,7]. Recent development of in vivo
visualisation of blood vessels using multiphoton microscopy
provides a powerful tool to address these issues with high
resolution. Our present findings uncovered a previously unreport-
ed dichotomy in the reactions of intermediate diameter cortical
versus dural vessels in the classical GTN model of headaches. These
findings extend our knowledge about the complex behaviour of
trigeminovascular system and, in particular, meningeal vessels
innervated by trigeminal nerves where pain is likely generated.
Methodological aspects
Multiphoton microscopy used in the current project has several
advantages over the previously employed methods such as
transcranial Doppler [8], single-photon emission computed
tomography [17], angiography [6,18] or intravital epifluorescent
microscopy [9]. Thus, multiphoton imaging provides unprece-
dented high temporal and spatial resolutions of the vascular
elements investigated in this study. Importantly, our approach
allows clear distinction between different layers of brain vessels
and unambiguous separation of dura mater vessels from the cortical
Figure 3. The action of of GTN onmeningeal vessels in open cranial window preparation. A, examples of meningeal vessels before (upper
image) and after GTN administration (lower image). B, the normalized diameter of meningeal arterioles after injection of the GTN (filled circles) or
vehicle (empty circles), real diameter before application 17.462 mm for meningeal arterioles and 22.864 mm for meningeal venules. C, comparison of
changes in the area under curve in GTN vs vehicle in meningeal arterioles (n = 6 and n=4, respectively, *** = P,0.001), D and E, the same for
meningeal venules (n = 5 and n= 4, respectively). Note that GTN changed the diameter of arterioles but not venules. Scale bar 40 mm.
doi:10.1371/journal.pone.0089699.g003
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ones without physical removal of dura mater (Figure 1). In our pilot
experiments with removed dura mater we clearly observed cortical
vessels with preserved morphology (Figure S4). Moreover, we
found that cortical vessels dilate upon injection of GTN (Figure S4)
similarly to the experiments with preserved dura mater. Such
similarity indicated that the functional state of the cortical vessels
was not significantly affected by the microsurgery. Furthermore,
these pilot experiments suggested that GTN-induced cortical
vasodilation develops independently from reflexes initiated from
dura mater or diffusible agents released from that part of meninges.
In contrast to previously used methods, multiphoton imaging
allows to study the diameter changes not only in large but also in
mid-sized vessels, which present a large fraction of peripheral
vascular bed. This is important because such the meningeal vessels
of this calibre are innervated by CGRP expressing nerves [20].
Previously, by measuring venous distensibility in humans it has
been observed that GTN dilates veins more so than arteries [32].
Here, we found that veins are relatively insensitive to GTN
challenge. This could be related to the small diameter of the vessels
visualized in our study and/or region-specific sensitivity of
intracranial vessels to the NO donor. Indeed, the proximal parts
of isolated middle cerebral artery have been previously shown to
have a different sensitivity to GTN compared to the distal parts
[21].
Effect of GTN on meningeal vessels
Vasodilation of cortical vessels induced by GTN was observed
by many other groups [3,17,18,19,22] and the findings of the
present study are consistent with those observations. The more
intriguing finding is the opposite, vasoconstrictory effect of GTN
on meningeal (dura mater) vessels. Our findings with small diameter
vessels supplement recent study employing intravital microscopy
combined with LDF where it has shown a dilatory effect of GTN
on large meningeal arteries [19]. Apart from different targets
(microvessels versus large diameter arteries) there are several other
obvious dissimilarities between our experimental approach and
that of Gozalov and co-workers such as a difference in the
concentration and route of GTN injection (20 mg/kg as i.v. bolus
versus 10 mg/kg i. p. in our study). The issue of reliable animal
migraine models (including the concentration of the trigger in
GTN model) was recently discussed [33]. In our study we tried to
minimize influence of several important parameters on outcome of
Figure 4. The action of L-NAME (filled circles) and vehicle (open circles) on the diameter of cortical and meningeal vessels in open
cranial window preparation. A, the time of changes in cortical arterioles (real diameter 38.166 mm), B, cortical venules (real diameter
46.4613 mm), D, meningeal arterioles (real diameter 20.765 mm) and E, meningeal venules (real diameter 24.167 mm), respectively. C and F,
quantification of results (n = 9, 4, 8, 8 for meningeal arterioles, meningeal venules, cortical arterioles and cortical venules, respectively, *** = P,0.001,
** = P,0.01). Notice constriction of cortical but not of meningeal vessels.
doi:10.1371/journal.pone.0089699.g004
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the study: we tested GTN under two different anaesthesia
methods, used vehicle with ethanol and propylene glycol as a
control, compared two different access ways (cranial window and
thinned skull). The insignificant effect of GTN in our study on
cortical arterioles in the ‘‘thinned-skull’’ preparation can be
explained by the fact that this preparation offers lower penetration
depth and lower signal-to-noise ratio in the deeper layers (i.e., in
the cortex) as compared to cranial window, whereas in the
meninges variability (signal-to-noise ratio) is similar between
thinned skull and cranial window.
Interestingly, Greco et al [22] using an LDF probe positioned in
the meninges (somewhat above the cortical surface) found biphasic
changes in the dural blood flow, which consisted in an initial fast
decline followed by a progressive increase in the regional blood
flow. The initial dip observed in that study could potentially be
linked to the acute vasoconstriction we report here.
Potential morphological and neurochemical mechanisms
of differential reactivity of cortical and meningeal vessels
As illustrated schematically in Figure 5, there are several factors
that may lead to the striking opposite reaction of cortical versus
meningeal vessels to the very same treatment with GTN. Notably,
there is an important difference in the local cellular environment
regulating blood flow in cortex and in meninges: astrocytes control
cortical (and pial) blood flow via their end feet that adhere to the
vessel wall to form blood-brain barrier [34,35], but such glial
control is missing in dura mater vessels. Oppositely, dura mater is
enriched with mast cells [36], and as GTN presumably
degranulates mast cells [37], this could explain the vasoconstric-
tion induced by this agent. Our preliminary unpublished data
indicate strong vasoconstrictor effect in meninges induced by mast
cell degranulating compounds (these pilot experiments will
constitute the core of a future study). This additional vasocon-
stricting factor may overpower the direct vasodilatory effect of
GTN in meningeal vessels, leading to the net decrease in
meningeal artery diameter as reported here.
Vessel wall organization itself is also strikingly different between
these vessel types: the walls of cortical vessels are part of the blood-
brain barrier, which further includes endothelial cells with tight
junctions and astrocytic end feet. Meningeal vessels, in contrast, lie
inside the tight grooves of the cranium, and the walls of these
vessels do not form the same kind of barrier as in cortical vessels.
Interestingly, it has been suggested that, at least in humans, due to
anatomical features the intracranial parts of dural meningeal
artery cannot dilate [38], hence leaving room only for constriction
in response to drugs or other stimuli.
In our study, we imaged small to medium-sized calibre vessels
(for example, meningeal arterioles had the mean diameter of
17.462 mm). This is an important fact, because responses to
compounds and stimulations may differ between proximal and
distal parts of the meningeal and cortical vessels. It was shown, for
example, that certain parts of the porcine meningeal artery are
insensitive to the 5-hydroxytryptamine receptor agonist sumatrip-
tan [39]. In another recent study, authors described layer-specific
dilation of cortical penetrating arterioles to activation of the
nucleus basalis of Meynert [40].
Some vasoactive substances, for example prostaglandins, can
dilate or constrict vessels depending on type of vessels involved or
molecular pathways involved [41]. Acetylcholine was shown to
constrict simultaneously epicardial arteries and dilate smaller
resistance vessels, depending on the interplay between direct
vasoconstriction and endothelium-derived NO-mediated vasodi-
lation [42].
From the clinical perspective our findings perhaps are more
relevant not to the delayed (‘‘migraine-like’’ headache) but rather
to the early acute headache observed shortly after GTN
administration [43]. One possible mechanism of this acute pain
could be that the opposite vasodynamics in meningeal and cortical
districts initiates a cascade of events leading to headache. Any
direct action of NO on vessels may involve astrocytes, which
control the blood flow in cortical areas, and mast cells, which
surround not only dural vessels but also nociceptive nerve endings
located in meninges [44]. Further studies are needed to clarify
these potential mechanisms.
Conclusion
In conclusion, we report here, for the first time, high resolution
imaging of the effects of the headache-triggering agent GTN on
medium-sized meningeal arteries and venules and compare them
to cortical arteries and venules. We show that, in both regions,
venules are essentially inert, whereas arterioles react to GTN in
two opposing ways, i.e. by constriction in dura mater and dilation in
the cortex. These data provide new insights on non-uniform
vascular reactivity, which are important for understanding of the
mechanisms of headache.
Supporting Information
Figure S1 The action of GTN (filled circles) and vehicle (empty
circles) on the diameter of cortical and meningeal arterioles (red)
and venules (blue) in thinned skull preparation. A, the time of
changes in cortical arterioles (real diameter 31.366 mm), B, cortical
venules (real diameter 27.767 mm), D, meningeal arterioles (real
diameter 22.563 mm) and E, meningeal venules (real diameter
23.665 mm), respectively. C and F, quantification of results (n = 3,
2, 4, 3 for meningeal arterioles, meningeal venules, cortical
arterioles and cortical venules, respectively, ** = P,0.01).
(TIF)
Figure S2 The action of GTN on systemic systolic (filled circles)
and diastolic (empty circles) blood pressure in rats (n = 4).
(TIF)
Figure 5. Schematic presentation of potential mechanisms for
opposite modulation of dura mater and pial/cortical vessels by
GTN. In dura mater occupied by mast cells and densely innervated by
trigeminal and autonomous nerves GTN can induce vasoconstriction of
small vessels either directly, or via release of vasoconstrictory agents
from mast cells or through the neuronal control. The functional
outcome depends on the combination of vasodilatatory versus
vasoconstrictory agents and on the receptor profile. The dilatatory
effect of GTN in pial/cortical vessels could be due to the direct action of
this agent on the vessel wall or mediated via astrocytes releasing NO.
doi:10.1371/journal.pone.0089699.g005
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Figure S3 The action of GTN on the diameter of cortical and
meningeal arterioles (red) and venules (blue) in open window
preparation under urethane anaesthesia. A, the time of changes
in cortical arterioles, B, cortical venules, D, meningeal arterioles
and E, meningeal venules, respectively. C and F, quantification of
results (n = 5, 5, 5, 4 for meningeal arterioles, meningeal venules,
cortical arterioles and cortical venules, respectively,
*** = P,0.001).
(TIF)
Figure S4 Cortical vessels in the in vivo imaging experiment with
removed dura mater. 3D projection of cortical vessels in the in vivo
imaging experiment with removed dura mater: A, upper view (look-
through, or view from the top), B, side view of the same area (3D
projection). Note the absence of dural vessels. Calibration bar –
15 mm. C, effect of GTN (i.p. injection, 10 mg/kg) on the
diameter of cortical vessels. Note the transient vasodilation of
cortical vessels in response to GTN.
(TIF)
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